?? Pioneering Biomedical Solutions: IBT Bioservices' Fight Against Filoviruses IBT Bioservices leads the charge against Hemorrhagic Fever Viruses, including Filoviruses like Ebola, Sudan, and Marburg viruses, with tailored reagents and services designed to combat these lethal pathogens. For over 15 years, our team has been at the forefront of infectious disease research, specializing in preclinical testing to evaluate novel therapies and strategies against some of the world's deadliest viruses. Filovirus research presents unique challenges, notably the need for high containment laboratories, which can escalate costs and prolong therapeutic development timelines. However, our expert scientists have developed innovative solutions to accelerate progress. Key to our approach is the use of surrogate pseudotype models, replicating authentic filoviruses under controlled conditions. This enables us to conduct significant preclinical testing within biosafety level 2 (BSL-2) facilities, ensuring both efficiency and safety. Beyond the lab, we provide comprehensive support to researchers worldwide, offering a diverse range of high-quality research use reagents such as monoclonal antibodies, ELISA kits, glycoproteins and viral proteins tailored to support their filovirus research. By fostering collaboration and innovation, IBT Bioservices continues to lead the way in biomedical research, working tirelessly towards a world free from the threat of infectious diseases. Visit our website for more information or get in touch with one of our team members directly!? ? Website: https://lnkd.in/eY6Kd9vs Email: [email protected]? #BiomedicalInnovation #FilovirusResearch #PreclinicalTesting #EbolaResearch #IBTBioservices
